Application number | Title of the application | Filing Date | Status |
---|
96/000262 | VIRAL CONJUNCTIVITIS TREATMENT USING RANPIRNASE AND/OR AMPHINASE | Jun 27, 2018 | Pending |
96/000248 | METHOD OF FEEDING LIVESTOCK TO IMPROVE CARCASS CHARACTERISTICS | Dec 28, 2017 | Pending |
90/014054 | SYSTEMS AND METHODS FOR COUNTING CELLS AND BIOMOLECULES | Dec 14, 2017 | Issued |
90/014027 | METHOD FOR THE TREATMENT OF SYMPTOMS RELATED TO NORMAL HORMONAL VARIATIONS IN WOMEN | Oct 9, 2017 | Issued |
15/705553 | Local Intraosseous Administration of Bone Forming Agents and Anti-Resorptive Agents, and Devices Therefor | Sep 14, 2017 | Abandoned |
90/013963 | Targeting Rare Human PCSK9 Variants for Cholesterol Treatment | Jun 13, 2017 | Issued |
Array
(
[id] => 14115655
[patent_doc_number] => RE047333
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2019-04-02
[patent_title] => Pharmaceutical formulations containing dopamine receptor ligands
[patent_app_type] => reissue
[patent_app_number] => 15/598784
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12101
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15598784
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/598784 | Pharmaceutical formulations containing dopamine receptor ligands | May 17, 2017 | Issued |
Array
(
[id] => 14167955
[patent_doc_number] => RE047350
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2019-04-16
[patent_title] => Pharmaceutical formulations containing dopamine receptor ligands
[patent_app_type] => reissue
[patent_app_number] => 15/598971
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12119
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15598971
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/598971 | Pharmaceutical formulations containing dopamine receptor ligands | May 17, 2017 | Issued |
15/461054 | REGENERATIVE AUTOLOGOUS BONE MARROW CELL THERAPIES AND METHODS FOR THEIR USE IN THE TREATMENT OF JOINT PAIN | Mar 15, 2017 | Abandoned |
90/013885 | T CELL RECEPTOR-DEFICIENT T CELL COMPOSITIONS | Dec 26, 2016 | Pending |
Array
(
[id] => 13247789
[patent_doc_number] => RE047141
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2018-11-27
[patent_title] => Methods of treating fibrosis, cancer and vascular injuries
[patent_app_type] => reissue
[patent_app_number] => 15/382065
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 33
[patent_no_of_words] => 24064
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15382065
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/382065 | Methods of treating fibrosis, cancer and vascular injuries | Dec 15, 2016 | Issued |
Array
(
[id] => 13219413
[patent_doc_number] => RE047122
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2018-11-13
[patent_title] => 2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors
[patent_app_type] => reissue
[patent_app_number] => 15/382135
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 26268
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15382135
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/382135 | 2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitors | Dec 15, 2016 | Issued |
Array
(
[id] => 11857304
[patent_doc_number] => RE046518
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2017-08-22
[patent_title] => 'Compositions relating to a mutant Clostridium difficile toxin and methods thereof'
[patent_app_type] => reissue
[patent_app_number] => 15/366702
[patent_app_country] => US
[patent_app_date] => 2016-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 56
[patent_no_of_words] => 64865
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15366702
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/366702 | Compositions relating to a mutant Clostridium difficile toxin and methods thereof | Nov 30, 2016 | Issued |
Array
(
[id] => 13115455
[patent_doc_number] => RE047045
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2018-09-18
[patent_title] => Compositions and methods for treating macular degeneration
[patent_app_type] => reissue
[patent_app_number] => 15/343016
[patent_app_country] => US
[patent_app_date] => 2016-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10617
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15343016
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/343016 | Compositions and methods for treating macular degeneration | Nov 2, 2016 | Issued |
90/013846 | MONITORING AMPLIFICATION OF DNA DURING PCR | Oct 26, 2016 | Issued |
Array
(
[id] => 11457128
[patent_doc_number] => 20170051033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'Variants of C-Type Natriuretic Peptide'
[patent_app_type] => utility
[patent_app_number] => 15/332793
[patent_app_country] => US
[patent_app_date] => 2016-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 61
[patent_no_of_words] => 74178
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15332793
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/332793 | Variants of C-Type Natriuretic Peptide | Oct 23, 2016 | Abandoned |
Array
(
[id] => 14848327
[patent_doc_number] => RE047607
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2019-09-17
[patent_title] => Luciferase signal enhancing compositions
[patent_app_type] => reissue
[patent_app_number] => 15/292259
[patent_app_country] => US
[patent_app_date] => 2016-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 46
[patent_no_of_words] => 16812
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15292259
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/292259 | Luciferase signal enhancing compositions | Oct 12, 2016 | Issued |
Array
(
[id] => 13206035
[patent_doc_number] => RE047115
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2018-11-06
[patent_title] => Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis
[patent_app_type] => reissue
[patent_app_number] => 15/230189
[patent_app_country] => US
[patent_app_date] => 2016-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9402
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15230189
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/230189 | Composition and method for delivery of BMP-2 amplifier/co-activator for enhancement of osteogenesis | Aug 4, 2016 | Issued |
Array
(
[id] => 14084269
[patent_doc_number] => RE047316
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2019-03-26
[patent_title] => Oral formulations of ospemifene
[patent_app_type] => reissue
[patent_app_number] => 15/191316
[patent_app_country] => US
[patent_app_date] => 2016-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2033
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15191316
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/191316 | Oral formulations of ospemifene | Jun 22, 2016 | Issued |
Array
(
[id] => 13075913
[patent_doc_number] => RE047009
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2018-08-28
[patent_title] => HDAC inhibitors and therapeutic methods using the same
[patent_app_type] => reissue
[patent_app_number] => 15/182061
[patent_app_country] => US
[patent_app_date] => 2016-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 30216
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15182061
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/182061 | HDAC inhibitors and therapeutic methods using the same | Jun 13, 2016 | Issued |